Call for Session, Presentation, and Short Course Abstracts
Read Submission Guidelines| Submit
Abstract Submission Deadline: Tuesday, August 4
Notification: Week of October 05
Final PowerPoint Presentations Due: January 18, 2027
Forum Dates: February 8-10, 2027
Location: BETHESDA NORTH MARRIOTT HOTEL & CONFERENCE CENTER | BETHESDA, MD
Questions: Contact Lynda.Fisher@DIAglobal.org
Call for Abstracts
Are you a professional working in regulatory affairs, regulatory operations, regulatory information management (RIM), regulatory data management, regulatory intelligence, electronic submissions, digital transformation, AI and emerging technologies, or regulatory technology? If so, DIA wants to hear from you!
The Regulatory Submissions, Information, and Data Management (RSIDM) Forum continues to evolve to meet the needs of organizations at all levels of regulatory maturity—from emerging biotech companies and to large global enterprises. As regulatory environments become increasingly data-driven, interconnected, and technology-enabled, RSIDM provides a forum for sharing practical experiences, innovative approaches, and lessons learned that advance regulatory excellence.
We strongly encourage abstract submissions from small, mid-sized, and large organizations and welcome diverse perspectives from across the life sciences ecosystem. As part of your submission, please include the stakeholder groups your session aims to engage (e.g., industry representatives, regulators, academia, technology providers, or patients).
Let your voice help shape the future of regulatory submissions, information, and document management. Submit your abstract today!
Tracks
Track 1: Establishing Robust Foundations for a Sustainable Regulatory Ecosystem
How do I build the capability?
This track focuses on the practical establishment and execution of core RSIDM capabilities across process, data, and technology. It examines how organizations define and implement foundational processes spanning document authoring, structured data management, regulatory submissions, and compliance outputs while adhering to the latest technical guidelines and data standards.
Track 2: Optimizing Processes and Procedures:
How do I make the capability perform better?
This track is designed for regulatory professionals focused on improving day-to-day execution of regulatory submissions and data processes in a complex, global environment. The typical attendee is a regulatory leader (Examples: senior manager, director, or global process owner) working in mid-to-large pharmaceutical, biotech, or regulatory service organizations, where they are responsible for delivering submissions, improving process efficiency, and scaling operations across regions and systems.
Track 3: Automation and Emerging Technologies
What technologies can help me?
This cross-cutting focus area provides thought-provoking insights and new perspectives on how to effectively adopt innovative technologies into a company or organization and the systematic approach that is needed to assess the effectiveness and impact of the adopted innovations.
Track 4: Strategic Leadership and Organizational Readiness
How do I transform the organization?
This track explores the organizational, leadership, and strategic forces that drive successful regulatory transformation and prepare companies for the rapidly evolving global landscape. The track examines how forward thinking planning, agile governance, and enterprise aligned regulatory strategy enable organizations to build truly future ready regulatory capabilities.
Sessions will move beyond foundational execution and technology optimization to address the broader structural enablers of regulatory excellence. Key themes include defining and building next generation regulatory organizations; transforming operating models across centralized and decentralized structures; strengthening global and regional governance; and addressing capability gaps through talent development and workforce transformation.
Submission Guidelines
To streamline your submission process and avoid possible delays, DIA strongly encourages you to submit your abstract as early as possible. Do not wait until the last day.
Prepare your abstract in advance of accessing the DIA website. Abstract information should be copied and pasted from a prepared document as plain text. All of the below fields are required.
- Author Information
- Abstract Information
- Abstract Title: (125 characters including spaces)
- Interest Area: Choose from the drop down
- Keywords: Provide one or more keywords to highlight your abstract. Examples of keywords: Personalized Medicine, Health Technology Assessment, etc. (100 characters)
- Level of Difficulty: Beginner, Intermediate, or Advanced
- Learning Objectives: Provide 2-3 learning objectives that clearly explain what participants should be able to do after attending this event. For a list of suggested verbs to create these objectives, click here. (400 Characters)
- Overview: *Please provide 2-3 sentences summarizing your abstract. This summary will be used as the overview description in the DIA program for marketing purposes (250 Characters including spaces)
- Abstract Details: *Please provide complete details about your abstract. Information such as scientific, technical, process issues, design/methods, results/outcomes, case studies, statistics, key findings, etc., that would support your proposal should be included here. This information will be used by the Program Committee to learn more about the purpose of your abstract. Is there an interactive component to your topic? If so, please indicate in the abstract details how you would be able to include an interactive learning experience for attendees. (2000 Characters including spaces)
We ask that all abstracts be noncommercial and not appear as a marketing opportunity. Submitters must adhere to DIA’s Policy Concerning Promotion of Products and Services from the Podium.
